- Home
- KNSA vs VIRT Comparison
KNSA vs VIRT Comparison
Compare KNSA & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- VIRT
- Stock Information
- Founded
- KNSA 2015
- VIRT 2008
- Country
- KNSA United Kingdom
- VIRT United States
- Employees
- KNSA N/A
- VIRT N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- VIRT Investment Bankers/Brokers/Service
- Sector
- KNSA Health Care
- VIRT Finance
- Exchange
- KNSA Nasdaq
- VIRT Nasdaq
- Market Cap
- KNSA 2.6B
- VIRT 2.8B
- IPO Year
- KNSA 2018
- VIRT 2015
- Fundamental
- Price
- KNSA $41.77
- VIRT $34.03
- Analyst Decision
- KNSA Strong Buy
- VIRT Hold
- Analyst Count
- KNSA 6
- VIRT 7
- Target Price
- KNSA $51.33
- VIRT $41.43
- AVG Volume (30 Days)
- KNSA 461.3K
- VIRT 972.3K
- Earning Date
- KNSA 10-28-2025
- VIRT 10-29-2025
- Dividend Yield
- KNSA N/A
- VIRT 2.85%
- EPS Growth
- KNSA N/A
- VIRT 132.69
- EPS
- KNSA 0.47
- VIRT 4.62
- Revenue
- KNSA $597,973,000.00
- VIRT $2,694,104,000.00
- Revenue This Year
- KNSA $62.63
- VIRT N/A
- Revenue Next Year
- KNSA $29.93
- VIRT N/A
- P/E Ratio
- KNSA $89.00
- VIRT $7.36
- Revenue Growth
- KNSA 55.68
- VIRT 41.05
- 52 Week Low
- KNSA $17.82
- VIRT $31.89
- 52 Week High
- KNSA $42.93
- VIRT $45.77
- Technical
- Relative Strength Index (RSI)
- KNSA 64.60
- VIRT 43.21
- Support Level
- KNSA $39.61
- VIRT $33.50
- Resistance Level
- KNSA $42.93
- VIRT $34.89
- Average True Range (ATR)
- KNSA 1.43
- VIRT 0.79
- MACD
- KNSA 0.19
- VIRT -0.13
- Stochastic Oscillator
- KNSA 79.30
- VIRT 18.23
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About VIRT Virtu Financial Inc.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.